Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01330667
Other study ID # ELF for Hyperbilirubinemia
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date July 2015
Est. completion date June 2016

Study information

Verified date November 2018
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators propose to conduct an exploratory pilot study, enrolling 30 exclusively breastfeeding newborns 36-96 hours of age, whose Total Serum Bilirubin (TSB) is within 0.1-3 mg/dl of the American Academy of Pediatrics (AAP)-recommended treatment thresholds for Phototherapy (PT). These newborns will be randomly assigned to receive either 10 cc extensively hydrolyzed formula following each breastfeeding using cup, spoon or syringe, or to continue exclusive breastfeeding. Infants will be followed at 1, 2, 3 and 6 months to assess breastfeeding duration and use of formula and complementary foods. Our hypothesis is that limited, small amounts of formula administered without a bottle immediately following breastfeeding might reduce the incidence of severe hyperbilirubinemia among newborns at increased risk of TSB exceeding AAP-recommended thresholds for beginning phototherapy.


Description:

Inclusion criteria

- Healthy infants ≥ 35 weeks

- Neonates 36-96 hours old

- Exclusively breastfeeding

- TSB 0.1-3 mg/dl below AAP-recommended PT threshold

- TSB < 6 hours ago

- Mothers English-speaking or Spanish-speaking

Outcome Measures

- Primary outcome: Total Serum Bilirubin

- Secondary clinical outcomes: Phototherapy, hospital readmission, exclusive and partial breastfeeding at 1 week, 1 month, 2 months, and 3 months; breastfeeding self-efficacy


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date June 2016
Est. primary completion date July 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 96 Hours
Eligibility Inclusion Criteria:

- Healthy infants = 35 weeks

- Neonates 36-96 hours old

- Exclusively breastfeeding

- TSB 0.1-3 mg/dl below AAP-recommended PT threshold

- TSB < 6 hours ago

- Mothers English-speaking or Spanish-speaking

Exclusion Criteria:

- Infants who have already received formula

- Infants who have received or are receiving Level II or Level III

- Infants who have already lost = 10% birth weight

- Infants with Glucose-6-phosphate dehydrogenase deficiency, positive direct antigen testing, cephalohematoma or other extensive bruising

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Nutramigen Infant Formula
Investigators will advise to supplement with 10cc's of extensively hydrolyzed formula immediately following each breastfeeding until TSB declines.

Locations

Country Name City State
United States University of California, San Francisco Medical Center San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary TSB meeting or exceeding AAP-recommended phototherapy treatment threshold. The investigators will compare measured TSB to AAP guideline recommendations for phototherapy treatment and confirming with Bili Tool, an automated program designed for this purpose. Up to two weeks after birth
Secondary Receipt of phototherapy and hospital readmission, exclusive and partial breastfeeding at 1 week, 1 month, 2 months, and 3 months; breastfeeding self-efficacy The investigators will ask mothers whether the infant received any breast milk in the last 24 hours. For infants whose mothers state they have received breast milk in the last 24 hours, the investigators will ask mothers whether the infant received anything other than breast milk in the last 24 hours. The investigators will ask mothers whether the infant received anything other than breast milk since the prior assessment. The investigators will query subjects using the Breastfeeding Self Efficacy Scale, short form, at enrollment, 1week and at 1 month. Up to three months after birth
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04868019 - Role of Fenofibrate in Indirect Neonatal Hyperbilirubinemia: a Randomized Control Trial N/A
Completed NCT00114543 - Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight Phase 3
Completed NCT02000830 - Follow up Study of Patients Having Participated in Clinical Trial 64,185-204
Completed NCT01887327 - Stannsoporfin With Light Therapy for Newborn Babies With Jaundice Phase 2
Completed NCT05356273 - The Effect of Massage on the Bilirubin Level in Term Infants Receiving Phototherapy N/A
Suspended NCT03741803 - Relationship Between Delayed Cord Clamping at Birth and Neonatal Bilirubin Levels in Parturients With a Prior Child Requiring Therapy for Neonatal Jaundice N/A
Recruiting NCT03876678 - The Efficacy of Oral Probiotics on Neonatal Hyperbilirubinemia N/A
Not yet recruiting NCT05365984 - Intelligent Follow-up of Neonatal Jaundice Based on Early Indicators and Internet Communications N/A
Recruiting NCT04251286 - Screening and Follow-up Study of Neonatal Jaundice Based on Mobile Network
Completed NCT03723005 - A Light Emitting Diode (LED) Mattress for Phototherapy of Jaundiced Newborns
Recruiting NCT06087874 - Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice Phase 2
Completed NCT03624335 - Influence of Umbilical Cord Clamping Time in the Newborn N/A
Recruiting NCT06324799 - The Effect of Position Change Frequency on Hyperbilirubinemia N/A
Recruiting NCT06209489 - White Cover and Massage Impact on Bilirubin Levels and Phototherapy Duration in Newborns N/A
Completed NCT03824990 - Multi-center Clinical Study on Neonatal Hyperbilirubinemia N/A
Completed NCT01169740 - Transcutaneous Measurement of Jaundice in the Newborn N/A
Recruiting NCT06238349 - Hyperbilirubinemia in Full-term Neonates Phase 4
Completed NCT03007563 - Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice N/A
Completed NCT01763632 - Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants N/A
Completed NCT01762189 - The Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants N/A